| Center |
| Faculty of Medicine and Odontology |
| Departament |
| Pharmacology |
| Lecturers in charge |
| Sin datos cargados |
| Met. Docent |
| Met. Avaluació |
| - - |
| Bibliografia |
| BIBLIOGRAFÍA RECOMENDADA CLARK. W.; BRATER, D.; JOHNSON, A. (1995) Goth farmacología médica. 13. ed., Ed. Mosby/Doyma Libros. ESPLUGUES, J. Perspectivas Terapéuticas con su Fundamento Farmacológico. Vol I al VII. Saber, Valencia. ESPLUGUES, J.V.; PIQUÉ, J.M.; PONCE, J. (1996). Terapéutica farmacológica de las enfermedades del aparato digestivo. EUNSA. FLOREZ, J.(2003). Farmacología Humana. 4a. ed., Ed. Masson-Salvat. Barcelona. GOODMAN GILMAN,; GOODMAN, L.S.; RALL, T.W.; MURAD, F. (2003). Las Bases Farmacológicas de la Terapéutica. (10a ed.) Editorial Médica Panamericana, Madrid. VELAZQUEZ, B. (1993). Farmacología. 16ª ed. Ed. Interamericana. Madrid. RANG, H.P.; DALE, M.M.; RITTER J.M. (2000). Farm |
| Continguts |
| PROGRAMME OF THEORETICAL LESSONS GENERAL PHARMACOLOGY 1. Introduction to pharmacology. Historical antecedents. Division of the pharmacology. Development of the Medication. 2. Pharmaco-kinetics. Temporary evolution of drugs. 3. Absorption. Drug transfer through biological membranes. 4. Distribution. Factors that affect distribution. 5. Biotransformation. Microsomal hepatic system and metabolism. 6. Renal excretion. 7. Bioavailability and dosage rules. 8. Drug action mechanism. 9. Dose-response relation. 10. Pharmacological interactions. 11. Adverse reactions to the medication. VEGETATIVE NERVOUS SYSTEM: CHEMICAL MEDIATORS 12. Anatomo-physiological bases of the VNS. 13. Cholinergic system I. 14. Cholinergic system II. 16. Adrenergic system I. 17. Adrenergic system II. 18. Pharmacology of the adrenergic termination. 19. Dopamine and Serotonin. CELLULAR MEDIATORS: INFLAMMATION AND IMMUNITY 20. Histamine. 21. Lipid mediators. 22. Non-steroidal anti-inflammatory drugs . 23. Glucocorticoids . 24. Immunomodulator drugs. PHARMACOLOGY OF THE MAIN ORGANS AND SYSTEMS 25. Pharmacology of the Central Nervous System. 26. Antipsychotic and antidepressants. 27. Neurodegenerative disorders and convulsivants. 28. Stimulants of the central nervous system and |